VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 627 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $260,694,369 | +9.2% | 7,683,300 | +1.8% | 0.43% | +4.9% |
Q1 2024 | $238,696,218 | -2.3% | 7,548,900 | -4.2% | 0.41% | -11.2% |
Q4 2023 | $244,439,426 | +102.6% | 7,882,600 | +75.8% | 0.46% | +55.4% |
Q3 2023 | $120,642,912 | +91.4% | 4,483,200 | +114.2% | 0.30% | +54.4% |
Q2 2023 | $63,026,252 | -46.4% | 2,093,200 | -34.8% | 0.19% | -59.8% |
Q1 2023 | $117,695,357 | -26.3% | 3,211,600 | -25.0% | 0.48% | -24.1% |
Q4 2022 | $159,771,867 | +128.6% | 4,279,325 | +47.7% | 0.63% | +79.0% |
Q3 2022 | $69,888,000 | -1.7% | 2,897,558 | +11.6% | 0.35% | -10.9% |
Q2 2022 | $71,098,000 | -22.0% | 2,596,703 | +9.2% | 0.40% | +1.5% |
Q1 2022 | $91,161,000 | -16.2% | 2,377,100 | -30.0% | 0.39% | +35.4% |
Q4 2021 | $108,789,000 | +32.5% | 3,396,480 | +21.9% | 0.29% | +22.6% |
Q3 2021 | $82,128,000 | +1503.7% | 2,786,869 | +1749.3% | 0.24% | +1136.8% |
Q2 2021 | $5,121,000 | -58.8% | 150,700 | -60.6% | 0.02% | -74.0% |
Q1 2021 | $12,440,000 | -66.9% | 382,758 | -63.3% | 0.07% | -73.9% |
Q4 2020 | $37,574,000 | +15821.2% | 1,043,158 | +16141.0% | 0.28% | +6900.0% |
Q2 2020 | $236,000 | -98.4% | 6,423 | -99.0% | 0.00% | -99.0% |
Q1 2020 | $14,980,000 | +448.3% | 650,188 | +596.9% | 0.38% | +2293.8% |
Q4 2019 | $2,732,000 | -97.5% | 93,300 | -97.7% | 0.02% | -98.4% |
Q3 2019 | $110,629,000 | +21.4% | 4,141,855 | +16.2% | 0.99% | +11.1% |
Q2 2019 | $91,093,000 | +50.5% | 3,563,877 | +32.0% | 0.89% | +38.5% |
Q1 2019 | $60,540,000 | -25.3% | 2,700,257 | -38.3% | 0.64% | -33.8% |
Q3 2018 | $81,009,000 | +17.4% | 4,374,139 | +39.3% | 0.97% | -11.6% |
Q1 2018 | $69,029,000 | -14.1% | 3,140,522 | -9.2% | 1.10% | -21.7% |
Q4 2017 | $80,355,000 | +218.3% | 3,457,598 | +214.4% | 1.40% | +188.1% |
Q3 2017 | $25,247,000 | -64.1% | 1,099,589 | -65.5% | 0.49% | -64.9% |
Q2 2017 | $70,357,000 | +11490.9% | 3,186,463 | +11866.1% | 1.38% | +8041.2% |
Q1 2017 | $607,000 | -97.0% | 26,629 | -96.5% | 0.02% | -98.7% |
Q3 2016 | $19,987,000 | – | 756,233 | – | 1.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |